Verstraete K L, Achten E, De Schepper A, Ramon F, Parizel P, Degryse H, Dierick A M
Department of Medical Imaging, University Hospital Ghent, Belgium.
J Belge Radiol. 1992 Aug;75(4):311-20.
Tumors of nerves are classified into benign (schwannoma and neurofibroma) and malignant nerve sheath tumors. Schwannomas almost always occur as solitary lesions, whereas neurofibromas may occur alone or in a greater number, especially in patients with the peripheral form of von Recklinghausen's disease. Benign nerve sheath tumors often present as asymptomatic, slowly growing soft tissue masses. Although malignant nerve sheath tumors are relatively rare, a sudden increase in the size of a lesion, in particular in a patient with neurofibromatosis, should raise the suspicion of malignant change. On computed tomography (CT) and magnetic resonance imaging (MR) a benign nerve sheath tumor usually appears as a well-defined, oval, spherical or fusiform mass with smooth borders and distinct outlines, located in the subcutaneous tissue or centered at the expected anatomic location of a nerve, with displacement of adjacent soft tissues. Generally nerve sheath tumors have a low density on unenhanced CT scans. On MR they are isointense to muscle on T1-weighted images, whereas on T2-weighted images the signal intensity is high. Both on CT and MR the degree of contrast enhancement is moderate to marked and may be homogeneous or inhomogeneous. MR has become the method of choice for evaluating the anatomic location, contour, and relation of a nerve sheath tumor to adjacent neural, vascular, and muscular structures. The imaging criteria for malignant nerve sheath tumors are not specific enough to distinguish them from other malignant soft tissue tumors, so that neither CT nor MR can establish a definite diagnosis.
神经肿瘤分为良性(神经鞘瘤和神经纤维瘤)和恶性神经鞘膜瘤。神经鞘瘤几乎总是表现为孤立性病变,而神经纤维瘤可能单独出现或数量较多,特别是在患有外周型冯·雷克林豪森病的患者中。良性神经鞘膜瘤常表现为无症状、生长缓慢的软组织肿块。虽然恶性神经鞘膜瘤相对少见,但病变大小突然增加,尤其是在患有神经纤维瘤病的患者中,应怀疑有恶变。在计算机断层扫描(CT)和磁共振成像(MR)上,良性神经鞘膜瘤通常表现为边界清晰的椭圆形、球形或梭形肿块,边界光滑、轮廓分明,位于皮下组织或位于神经的预期解剖位置中心,伴有相邻软组织移位。一般来说,神经鞘膜瘤在未增强的CT扫描上密度较低。在MR上,它们在T1加权图像上与肌肉等信号,而在T2加权图像上信号强度较高。在CT和MR上,对比增强程度为中度至明显,可均匀或不均匀。MR已成为评估神经鞘膜瘤的解剖位置、轮廓以及与相邻神经、血管和肌肉结构关系的首选方法。恶性神经鞘膜瘤的影像学标准不够特异,无法将其与其他恶性软组织肿瘤区分开来,因此CT和MR都不能确诊。